Text Size
38 studies found for:    " June 11, 2008":" July 11, 2008"[FIRST-RECEIVED-DATE]AND HIV[CONDITION]

Modify this search | How to Use Search Results

Show Display Options
Rank Status Study
21 Unknown † Establishing Normal Values for Neuropsychological Testing in HIV-negative Thais
Condition: HIV Infections
Intervention:
22 Completed Kaletra-isentress Treatment Evaluation
Condition: HIV Infections
Intervention: Drug: Kaletra + Isentress
23 Completed Impact of an HPV Vaccine in HIV-Infected Young Women
Condition: HIV Infection
Intervention: Biological: HPV vaccine for strains -6, -11, -16, and -18
24 Terminated Daily Co-trimoxazole Prophylaxis to Prevent Malaria in Pregnancy
Condition: Malaria in Pregnancy, With or Without HIV Infection
Interventions: Drug: Cotrimoxazole;   Drug: Sulfadoxine-pyrimethamine
25 Terminated HIV-1 Viral Dynamics in Subjects Initiating Raltegravir Therapy
Condition: HIV-1 Infection
Intervention: Other: blood drawing
26 Completed
Has Results 		Study Comparing Lopinavir/Ritonavir (LPV/r) + Emtricitabine/Tenofovir Disoproxil Fumarate (FTC/TDF) With a Nucleoside Sparing Regimen Consisting of Lopinavir/Ritonavir + Raltegravir (RAL)
Condition: Human Immunodeficiency Virus Infection
Interventions: Drug: lopinavir/ritonavir (LPV/r);   Drug: emtricitabine/tenofovir disoproxil fumarate (FTC/TDF);   Drug: raltegravir (RAL)
27 Completed
Has Results 		PMS Assessing the Long-term Efficacy and Safety of Nevirapine Therapy (Combined With Other ARV Drugs) in HIV-1 Positive Patients in Daily Clinical Practice.
Condition: HIV Infections
Intervention:
28 Withdrawn Directly Administered Antiretroviral Therapy (DAART) Among HIV-1infected Injecting Drug Users (IDUs) in Chennai, India
Conditions: HIV Infections;   Heroin Dependence
Interventions: Behavioral: Directly Administered Antiretroviral Therapy (DAART);   Behavioral: SAT
29 Completed
Has Results 		Adding Maraviroc to Antiretroviral Therapy for Suboptimal CD4 T-Cell Recovery Despite Sustained Virologic Suppression
Condition: HIV Infections
Intervention: Drug: Maraviroc
30 Completed Registry to Assess Long-term Outcome in HIV Subjects Who Participated in Phase 2 and 3 Clinical Trials Involving Vicriviroc (Study P04999)(COMPLETED)
Condition: HIV Infections
Interventions: Drug: Vicriviroc maleate;   Drug: Placebo;   Drug: Emtricitabine 200 mg/ tenofovir disoproxil fumarate 300 mg
31 Completed Trial of Cognitive Behavioral Therapy to Reduce Antiretroviral Therapy Side Effects
Conditions: HIV Infections;   Adverse Effects
Intervention: Behavioral: Cognitive-behavioral therapy
32 Completed Immune Responses to Pneumococcal Vaccination Among HIV-infected Subjects
Condition: HIV Infections
Interventions: Biological: 23-valent pneumococcal polysaccharide vaccine;   Biological: Placebo
33 Completed Study of the Antiviral and Immunological Effects of Intensification of Suppressive Antiretroviral Therapy With Maraviroc
Condition: HIV Infections
Intervention: Drug: Maraviroc
34 Completed GSK706769 Repeat Dose Study
Conditions: Healthy Subjects;   Infection, Human Immunodeficiency Virus
Intervention: Drug: GSK706769
35 Completed Linkage to Care - Part I
Condition: HIV
Intervention:
36 Completed Psychosocial Needs of YMSM
Condition: HIV+ YMSM
Intervention:
37 Completed Safety and Immunogenicity of a Candidate Tuberculosis (TB) Vaccine in HIV-positive Adults.
Condition: Tuberculosis (TB)
Interventions: Biological: GSK's candidate Mycobacterium tuberculosis vaccine 692342;   Biological: Control vaccine with the adjuvant system.;   Biological: Control vaccine with physiological saline
38 Completed Study of Hepatitis C Virus (HCV) Viral Kinetics in HIV/HCV and HCV Patients
Condition: Hepatitis C
Intervention:
To Top

Show previous page of results Previous Page (1-20) Studies Shown (21-38) Next Page
† Indicates status has not been verified in more than two years